- Home
- ETON vs BVS Comparison
ETON vs BVS Comparison
Compare ETON & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | BVS |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 716.8M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ETON | BVS |
|---|---|---|
| Price | $33.98 | $9.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $39.33 | $14.00 |
| AVG Volume (30 Days) | 334.0K | ★ 653.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | ★ 0.05 | 0.04 |
| Revenue | $79,950,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $40.90 | $7.52 |
| Revenue Next Year | $47.23 | $7.06 |
| P/E Ratio | $669.80 | ★ $232.25 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.31 | $5.81 |
| 52 Week High | $35.66 | $11.25 |
Technical Indicators
Market Signals| Indicator | ETON | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 64.75 | 56.20 |
| Support Level | $15.77 | $8.43 |
| Resistance Level | $35.66 | $11.00 |
| Average True Range (ATR) | 1.64 | 0.37 |
| MACD | 0.18 | 0.11 |
| Stochastic Oscillator | 84.84 | 79.41 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.